CAS登錄號(hào) | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
4213-38-1 | Alanine,N-(N-Acetyl-L-leucyl)-3-[p-[bis(2-chloroethyl)amino]phenyl]-, ethyl ester, L-(8CI); Alanine,N-(N-Acetyl-L-leucyl)-3-[p-[bis(2-chloroethyl)amino]phenyl]-, ethyl ester(7CI); NSC 69830 | ![]() | C23H35Cl2N3O4 | 詳情 | 供應(yīng)商 | |
24125-22-2 | Arginine,N-Acetyl-L-leucyl-L-leucyl- (9CI); Arginine,N2-[N-(N-Acetyl-L-leucyl)-L-leucyl]-, DL- (8CI); DL-Arginine,N2-[N-(N-Acetyl-L-leucyl)-L-leucyl]-; Leupeptin Ac-LL acid | ![]() | C20H38N6O5 | 詳情 | 供應(yīng)商 | |
125989-15-3 | Glycinamide,N-Acetyl-L-leucyl-L-methionyl-L-glutaminyl-L-tryptophyl-L-phenylalanyl-; L 659874 | ![]() | C40H55N9O8S | 詳情 | 供應(yīng)商 | |
129809-09-2 | Glycinamide,N-Acetyl-L-leucyl-L-a-aspartyl-L-glutaminyl-L-tryptophyl-L-phenylalanyl-; R396 | ![]() | C39H51N9O10 | 詳情 | 供應(yīng)商 | |
4033-42-5 | Glycine,N-Acetyl-L-leucyl-; Glycine,N-(N-Acetyl-L-leucyl)- (6CI,7CI,8CI); Acetylleucylglycine | ![]() | C10H18N2O4 | 詳情 | 供應(yīng)商 | |
160369-84-6 | HIV蛋白酶抑制劑 | L-Valinamide,N-Acetyl-L-leucyl-N-[(1S)-1-formyl-2-phenylethyl]- (9CI); L-Valinamide,N-Acetyl-L-leucyl-N-(1-formyl-2-phenylethyl)-, (S)- | ![]() | C22H33N3O4 | 詳情 | 供應(yīng)商 |
110044-82-1 | 鈣蛋白酶抑制劑I; N-乙;-L-亮氨酰-L-亮氨酰-L-正亮氨醛 | L-Leucinamide,N-Acetyl-L-leucyl-N-[(1S)-1-formylpentyl]-; L-Leucinamide,N-Acetyl-L-leucyl-N-(1-formylpentyl)-, (S)-; ALLN; ALLnL; CI-1 (peptide); CalpI; Calpain inhibitor I; MG 101; N-Acetyl-L-leucinyl-L-leucinyl-L-norleucinal | ![]() | C20H37N3O4 | 詳情 | 供應(yīng)商 |
110115-07-6 | L-Leucinamide,N-Acetyl-L-leucyl-N-[(1S)-1-formyl-3-(methylthio)propyl]-; L-Leucinamide,N-Acetyl-L-leucyl-N-[1-formyl-3-(methylthio)propyl]-, (S)-; CI 2; Calp II; Calpain inhibitor II; SUAM 312 | ![]() | C19H35N3O4S | 詳情 | 供應(yīng)商 | |
339990-02-2 | L-a-Asparagine,N-Acetyl-L-leucyl-L-prolyl-L-phenylalanyl-L-phenylalanyl-; 10:PN: WO03050139 SEQID: 15 claimed protein; 3: PN: WO0134631 PAGE: 35 claimedprotein; 7: PN: WO2004096845 SEQID: 5 claimed sequence; AS 602704 | ![]() | C35H46N6O8 | 詳情 | 供應(yīng)商 | |
105467-53-6 | L-Leucinamide,N-Acetyl-L-leucyl-N-(1-formyl-3-methylbutyl)- (9CI); SUAM 314 | ![]() | C20H37N3O4 | 詳情 | 供應(yīng)商 | |
105467-52-5 | L-Leucinamide,N-Acetyl-L-leucyl-N-(1-formylpentyl)- (9CI); SUAM 313 | ![]() | C20H37N3O4 | 詳情 | 供應(yīng)商 | |
24365-47-7 | L-Leucinamide,N-Acetyl-L-leucyl-N-[4-[(aminoiminomethyl)amino]-1-formylbutyl]- (9CI); Valeramide,2-(2-acetamido-4-methylvaleramido)-N-(1-formyl-4-guanidinobutyl)-4-methyl-(8CI); Acetyl-L-leucyl-L-leucylargininal; Leupeptin Ac-LL | ![]() | C20H38N6O4 | 詳情 | 供應(yīng)商 | |
354151-86-3 | L-a-Asparagine,N-Acetyl-L-leucyl-L-valyl-L-cysteinyl-N-(4-methyl-2-oxo-2H-1-benzopyran-7-yl)-(9CI); AC-LEU-VAL-CYS-ASP-AMC | ![]() | C30H41N5O9S | 詳情 | 供應(yīng)商 | |
24125-28-8 | L-Arginine,N-Acetyl-L-leucyl-L-leucyl-; Arginine,N2-[N-(N-Acetyl-L-leucyl)-L-leucyl]-, L- (8CI); L-Arginine,N2-[N-(N-Acetyl-L-leucyl)-L-leucyl]-; Leupeptin acid; N-Acetyl-L-leucyl-L-leucyl-L-arginine | ![]() | C20H38N6O5 | 詳情 | 供應(yīng)商 | |
292633-16-0 | L-a-Asparagine,N-Acetyl-L-leucyl-L-a-glutamyl-L-histidyl-N-(4-methyl-2-oxo-2H-1-benzopyran-7-yl)- | ![]() | C33H41N7O11 | 詳情 | 供應(yīng)商 | |
55123-66-5 | L-Leucinamide,N-Acetyl-L-leucyl-N-[(1S)-4-[(aminoiminomethyl)amino]-1-formylbutyl]-; L-Leucinamide,N-Acetyl-L-leucyl-N-[4-[(aminoiminomethyl)amino]-1-formylbutyl]-, (S)-; Acetyl-L-leucyl-L-leucyl-L-argininal; Leupeptin | ![]() | C20H38N6O4 | 詳情 | 供應(yīng)商 | |
24125-16-4 | LEUPEPTIN HYDROCHLORIDE; ACETYL-LEU-LEU-ARG-AL HCL; ACETYL-LEU-LEU-ARG-AL HYDROCHLORIDE; LEUPEPTIN HYDROCHLORIDE; leupeptin hydrochloride from*microbial source; LEUPEPTIN HYDROCHLORIDE, HIGH PURITY; L-Leucinamide, N-Acetyl-L-leucyl-N-4-(aminoiminomethyl)amino-1-formylbutyl-, monohydrochloride; Leupeptin hydrochloride >90% | ![]() | C20H39ClN6O4 | 詳情 | 供應(yīng)商 |